EP2787352A1 — Analysis system for a biological sample
Assigned to F Hoffmann La Roche AG · Expires 2014-10-08 · 12y expired
What this patent protects
The invention provides for an analysis system (100, 300, 400) for analyzing a biological sample (108) comprising an analyzer (102) with an analytical unit (106) for analyzing the biological sample to obtain an analysis result (140). The analyzer is configured for receiving a cart…
USPTO Abstract
The invention provides for an analysis system (100, 300, 400) for analyzing a biological sample (108) comprising an analyzer (102) with an analytical unit (106) for analyzing the biological sample to obtain an analysis result (140). The analyzer is configured for receiving a cartridge (110) comprising an identifier (114) and containing at least one reagent for analyzing the biological sample. The analyzer comprises an identification unit (116) for reading the identifier. The analyzer accepts the cartridge if the identifier is valid. The analysis system further comprises a protocol creation system (150, 104). Instructions cause the protocol creation system to: receive (200) analysis protocol parameters (164) from a user interface (158); generate (202) a custom analysis protocol (138) using the analysis protocol parameters; link (204) the custom analysis protocol to an invalid identifier which changes the invalid identifier into a valid identifier, and transfer (206) the user created analysis protocol associated with the now valid identifier to the analyzer controller.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.